🇺🇸 FDA
Patent

US 11041170

Multivalent vaccines for rabies virus and coronaviruses

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 11041170 (Multivalent vaccines for rabies virus and coronaviruses) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K39/12, A61K39/205